Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.75 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.71 |
| ▸ | FAAH | O00519 | 4/20 | 0.70 |
| ▸ | CASP2 | P42575 | 1/20 | 0.68 |
| ▸ | CNR1 | P21554 | 4/20 | 0.66 |
| ▸ | SELP | P16109 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8623682 | 1.00 | NAAA (0.75) | NAAADNM1FAAHCASP2CNR1 | |
| SCHEMBL1109952 | 1.00 | NAAA (0.75) | NAAADNM1FAAHCASP2CNR1 | |
| SCHEMBL1109946 | 1.00 | NAAA (0.75) | NAAADNM1FAAHCASP2CNR1 | |
| SCHEMBL283937 | 1.00 | NAAA (0.75) | NAAADNM1FAAHCASP2CNR1 | |
| SCHEMBL18265497 | 1.00 | NAAA (0.75) | NAAADNM1FAAHCASP2CNR1 | |
| SCHEMBL7111087 | 1.00 | NAAA (0.75) | NAAADNM1FAAHCASP2CNR1 | |
| SCHEMBL1289305 | 1.00 | NAAA (0.75) | NAAADNM1FAAHCASP2CNR1 | |
| SCHEMBL16390199 | 1.00 | NAAA (0.75) | NAAADNM1FAAHCASP2CNR1 | |
| SCHEMBL281727 | 1.00 | NAAA (0.75) | NAAADNM1FAAHCASP2CNR1 | |
| SCHEMBL26393721 | 1.00 | NAAA (0.75) | NAAADNM1FAAHCASP2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113173863-B | Preparation method of fatty acyl amino acid | 张家港格瑞特化学有限公司 | 2023-03-24 | — | — | CN | claimed |
| CN-113173863-A | Preparation method of fatty acyl amino acid | 张家港格瑞特化学有限公司 | 2021-07-27 | — | — | CN | claimed |
| CN-102448450-B | Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent | SYMRISE GMBH & CO KG | 2013-11-20 | — | — | CN | claimed |
| US-20130102520-A1 | THICKENED FABRIC SOFTENER | HENKEL AG & CO. KGAA (DE) | 2013-04-25 | — | — | US | claimed |
| CN-102448450-A | Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent | SYMRISE GMBH & CO KG | 2012-05-09 | — | — | CN | claimed |
| EP-0208961-A2 | Phospholipid analogs useful as paf synthesis inhibitors | MERCK & CO. INC. (US) | 1987-01-21 | — | — | EP | claimed |
| EP-4170026-A1 | MICROBIAL PRODUCTION OF ALKANOLAMIDES AND AMIDOAMINES AND USES THEREOF | Genomatica, Inc. (US) | 2023-04-26 | — | — | EP | disclosed |
| CN-113173863-B | Preparation method of fatty acyl amino acid | 张家港格瑞特化学有限公司 | 2023-03-24 | — | — | CN | disclosed |
| US-20210347962-A1 | COMPOSITIONS COMPRISING ESTOLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | BIOSYNTHETIC TECHNOLOGIES, LLC (US) | 2021-11-11 | — | — | US | disclosed |
| CN-113173863-A | Preparation method of fatty acyl amino acid | 张家港格瑞特化学有限公司 | 2021-07-27 | — | — | CN | disclosed |
| CN-111818934-A | Dermatological product | 西姆莱斯股份公司 | 2020-10-23 | — | — | CN | disclosed |
| US-20190292350-A1 | COMPOSITIONS COMPRISING ESTOLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | BIOSYNTHETIC TECHNOLOGIES LLC (US) | 2019-09-26 | — | — | US | disclosed |
| US-20190284499-A1 | LUBRICANT COMPOSITION | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2019-09-19 | — | — | US | disclosed |
| WO-1996018391-A2 | USE OF MONO AND BICARBOXYLIC ACID AMIDES FOR THE MANUFACTURE OF A MEDICAMENT ACTIVE AT THE PERIPHERAL CANNABINOID RECEPTOR | LIFEGROUP S.P.A. (IT) | 1996-06-20 | — | — | WO | disclosed |
| US-5506224-A | ADMINISTERING TO TREAT MAMMALIAN PATHOLOGIES INVOLVING MAST CELL DEGRANULATION AS CONSEQUENCE OF NEUROGENIC AND/OR IMMUNOGENIC HYPERSTIMULATION | LIFEGROUP S.P.A. (IT) | 1996-04-09 | — | — | US | disclosed |
| EP-0421441-B1 | Pantothenic acid derivatives | FUJIREBIO KK (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-5120738-A | Cardiovascular disorders | FUJIREBIO INC. (JP) | 1992-06-09 | — | — | US | disclosed |
| EP-0421441-A2 | Pantothenic acid derivatives | FUJIREBIO INC. (JP) | 1991-04-10 | — | — | EP | disclosed |
| US-4761404-A | RESPIRATORY SYSTEM DISORDERS, ANTIPYRETICS, ANALGESICS | MERCK & CO., INC. (US) | 1988-08-02 | — | — | US | disclosed |
| EP-0208961-A2 | Phospholipid analogs useful as paf synthesis inhibitors | MERCK & CO. INC. (US) | 1987-01-21 | — | — | EP | disclosed |